Morgan Stanley’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.32K | Hold |
6,000
| – | – | ﹤0.01% | 7039 |
|
|
2025
Q4 | $6.3K | Hold |
6,000
| – | – | ﹤0.01% | 7010 |
|
|
2025
Q3 | $14.9K | Hold |
6,000
| – | – | ﹤0.01% | 6779 |
|
|
2025
Q2 | $14.1K | Hold |
6,000
| – | – | ﹤0.01% | 6766 |
|
|
2025
Q1 | $7.8K | Buy |
6,000
+89
| +2% | +$164 | ﹤0.01% | 6874 |
|
|
2024
Q4 | $10.6K | Buy |
+5,911
| New | +$16.1K | ﹤0.01% | 6780 |
|
|
2024
Q1 | – | Sell |
-28
| Closed | -$190 | – | 7937 |
|
|
2023
Q4 | $190 | Buy |
28
+14
| +100% | +$144 | ﹤0.01% | 7349 |
|
|
2023
Q3 | $189 | Hold |
14
| – | – | ﹤0.01% | 7390 |
|
|
2023
Q2 | $359 | Hold |
14
| – | – | ﹤0.01% | 7406 |
|
|
2023
Q1 | $703 | Hold |
14
| – | – | ﹤0.01% | 7391 |
|
|
2022
Q4 | $558 | Hold |
14
| – | – | ﹤0.01% | 7547 |
|
|
2022
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 7589 |
|
|
2022
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 7696 |
|
|
2022
Q1 | $1K | Hold |
14
| – | – | ﹤0.01% | 7858 |
|
|
2021
Q4 | $2K | Hold |
14
| – | – | ﹤0.01% | 7803 |
|
|
2021
Q3 | $3K | Hold |
14
| – | – | ﹤0.01% | 7605 |
|
|
2021
Q2 | $3K | Hold |
14
| – | – | ﹤0.01% | 7490 |
|
|
2021
Q1 | $4K | Hold |
14
| – | – | ﹤0.01% | 7157 |
|
|
2020
Q4 | $4K | Buy |
+14
| New | +$3.54K | ﹤0.01% | 6809 |
|
|
2020
Q2 | – | Sell |
-1
| Closed | – | – | 6691 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6668 |
|
|
2019
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 6574 |
|
|
2019
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 6562 |
|
|
2019
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 6465 |
|
|
2019
Q1 | $3K | Hold |
1
| – | – | ﹤0.01% | 6405 |
|
|
2018
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 6425 |
|
|
2018
Q3 | $7K | Hold |
1
| – | – | ﹤0.01% | 6378 |
|
|
2018
Q2 | $11K | Sell |
1
-2
| -67% | -$29.6K | ﹤0.01% | 6289 |
|
|
2018
Q1 | $67K | Buy |
+3
| New | +$69K | ﹤0.01% | 5813 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6632 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6599 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6553 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6545 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6613 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6670 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6572 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6690 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6575 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6492 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 5766 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6442 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6316 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 5569 |
|
Other funds holding PHIO
VCM
VFT
HF
SRL
XT
Morgan Stanley's PHIO Position: Q1 2026 in Review
Morgan Stanley held its Phio Pharmaceuticals (PHIO) position steady in Q1 2026 at 6,000 shares worth $7.32K. The position accounts for ﹤0.01% of the portfolio, ranked #7039.
Morgan Stanley first reported a position in PHIO in Q1 2018 and has held it in 28 quarters since. The position peaked at $67K in Q1 2018. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.
- Morgan Stanley held 6,000 shares of Phio Pharmaceuticals worth $7.32K as of Q1 2026.
- Morgan Stanley left its Phio Pharmaceuticals share count unchanged in Q1 2026.
- Phio Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7039 holding.
- Morgan Stanley first reported a position in Phio Pharmaceuticals in Q1 2018 and has held it in 28 quarters since.
- Morgan Stanley's Phio Pharmaceuticals position peaked at $67K in Q1 2018.
- 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.